Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials-Reference-Cited by-同舟云学术

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials

Published:2016-10 Issue:10 Volume:4 Page:829-839
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Funder

German Federal Ministry for Education and Research

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference64 articles.

1. Statins in patients with chronic kidney disease: an attempt at recommendations;Curr Med Res Opin,2013

2. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis;Wanner;N Engl J Med,2005

3. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis;Fellström;N Engl J Med,2009

4. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial;Baigent;Lancet,2011

5. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis;Palmer;Ann Intern Med,2012

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global forecasting of chronic kidney disease mortality rates and numbers with the generalized additive model;BMC Nephrology;2024-09-02

2. Bempedoic Acid in Secondary Prevention;American Journal of Preventive Cardiology;2024-09

3. Low LCAT activity is linked to acute decompensated heart failure and mortality in patients with CKD;Journal of Lipid Research;2024-09

4. Exploring the nexus: The place of kidney diseases within the cardiovascular-kidney-metabolic syndrome spectrum;European Journal of Internal Medicine;2024-09

5. Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling.;European Journal of Pharmacology;2024-08